[
  {
    "genericName": "Metformin",
    "brandNames": ["Glucophage", "Cidophage", "Metforal"],
    "nameAr": "ميتفورمين",
    "drugClass": "Biguanide",
    "mechanism": "Decreases hepatic glucose production, increases insulin sensitivity",
    "indications": ["Type 2 diabetes mellitus", "Polycystic ovary syndrome", "Prediabetes prevention"],
    "contraindications": ["Severe kidney disease (eGFR <30)", "Metabolic acidosis", "Severe liver disease", "Heart failure", "Hypoxic conditions"],
    "sideEffects": ["Gastrointestinal upset", "Diarrhea", "Nausea", "Vitamin B12 deficiency (long-term)", "Lactic acidosis (rare)"],
    "interactions": ["Contrast dye (hold 48h before/after)", "Alcohol (increased lactic acidosis risk)"],
    "dosageAdult": "Start 500mg once or twice daily with meals, increase gradually to max 2000-2550mg/day in divided doses",
    "dosagePediatric": "≥10 years: Start 500mg twice daily, max 2000mg/day",
    "dosageElderly": "Start low, monitor kidney function closely",
    "routeOfAdministration": "Oral",
    "availabilityIraq": "widely_available",
    "approximateCost": "5,000-15,000 IQD per month",
    "requiresPrescription": true,
    "pregnancyCategory": "B",
    "lactationSafety": "Compatible",
    "renalAdjustment": "Contraindicated if eGFR <30, reduce dose if eGFR 30-45",
    "hepaticAdjustment": "Avoid in severe liver disease",
    "monitoringRequired": ["Kidney function every 3-6 months", "Vitamin B12 annually", "HbA1c every 3 months"],
    "specialInstructions": "Take with meals to reduce GI side effects. Start with low dose and increase gradually. Most affordable first-line diabetes medication in Iraq."
  },
  {
    "genericName": "Glibenclamide (Glyburide)",
    "brandNames": ["Daonil", "Gliben", "Diabeta"],
    "nameAr": "غليبنكلاميد",
    "drugClass": "Sulfonylurea",
    "mechanism": "Stimulates insulin secretion from pancreatic beta cells",
    "indications": ["Type 2 diabetes mellitus"],
    "contraindications": ["Type 1 diabetes", "Diabetic ketoacidosis", "Severe kidney or liver disease", "Sulfa allergy"],
    "sideEffects": ["Hypoglycemia", "Weight gain", "Nausea", "Skin rash"],
    "interactions": ["Alcohol (increased hypoglycemia)", "NSAIDs", "Beta-blockers (mask hypoglycemia symptoms)"],
    "dosageAdult": "Start 2.5-5mg once daily with breakfast, max 20mg/day",
    "dosagePediatric": "Not recommended",
    "dosageElderly": "Start 1.25mg daily, increase cautiously",
    "routeOfAdministration": "Oral",
    "availabilityIraq": "widely_available",
    "approximateCost": "3,000-10,000 IQD per month",
    "requiresPrescription": true,
    "pregnancyCategory": "C",
    "lactationSafety": "Use caution",
    "renalAdjustment": "Avoid if severe kidney disease",
    "hepaticAdjustment": "Avoid if severe liver disease",
    "monitoringRequired": ["Blood glucose", "HbA1c", "Signs of hypoglycemia"],
    "specialInstructions": "Take with breakfast. Educate patient on hypoglycemia symptoms. Widely available and affordable in Iraq."
  },
  {
    "genericName": "Insulin (Human Regular)",
    "brandNames": ["Actrapid", "Humulin R", "Insuman Rapid"],
    "nameAr": "إنسولين",
    "drugClass": "Insulin",
    "mechanism": "Replaces endogenous insulin, facilitates glucose uptake",
    "indications": ["Type 1 diabetes", "Type 2 diabetes (when oral agents fail)", "Diabetic ketoacidosis", "Hyperglycemic hyperosmolar state"],
    "contraindications": ["Hypoglycemia"],
    "sideEffects": ["Hypoglycemia", "Weight gain", "Injection site reactions", "Lipodystrophy"],
    "interactions": ["Alcohol", "Beta-blockers", "Corticosteroids (increase insulin requirement)"],
    "dosageAdult": "Individualized based on blood glucose. Typical 0.5-1 unit/kg/day divided",
    "dosagePediatric": "Individualized, typically 0.5-1 unit/kg/day",
    "dosageElderly": "Start low, adjust carefully",
    "routeOfAdministration": "Subcutaneous, IV (regular insulin only)",
    "availabilityIraq": "widely_available",
    "approximateCost": "Free through MOH diabetes centers, or 30,000-50,000 IQD per vial",
    "requiresPrescription": true,
    "pregnancyCategory": "B",
    "lactationSafety": "Compatible",
    "renalAdjustment": "May need dose reduction",
    "hepaticAdjustment": "May need dose reduction",
    "monitoringRequired": ["Blood glucose monitoring", "HbA1c", "Injection site rotation"],
    "specialInstructions": "Store in refrigerator. Once opened, can be kept at room temperature for 28 days. Available free at MOH diabetes centers in Iraq."
  },
  {
    "genericName": "Amlodipine",
    "brandNames": ["Norvasc", "Amlor", "Amlocard"],
    "nameAr": "أملوديبين",
    "drugClass": "Calcium Channel Blocker",
    "mechanism": "Blocks calcium channels in vascular smooth muscle, causing vasodilation",
    "indications": ["Hypertension", "Chronic stable angina", "Vasospastic angina"],
    "contraindications": ["Severe aortic stenosis", "Cardiogenic shock", "Hypotension"],
    "sideEffects": ["Peripheral edema", "Headache", "Flushing", "Dizziness", "Palpitations"],
    "interactions": ["Grapefruit juice (increases levels)", "Simvastatin (increase statin toxicity risk)"],
    "dosageAdult": "Start 5mg once daily, max 10mg/day",
    "dosagePediatric": "≥6 years: 2.5-5mg once daily",
    "dosageElderly": "Start 2.5mg once daily",
    "routeOfAdministration": "Oral",
    "availabilityIraq": "widely_available",
    "approximateCost": "5,000-20,000 IQD per month",
    "requiresPrescription": true,
    "pregnancyCategory": "C",
    "lactationSafety": "Use caution",
    "renalAdjustment": "No adjustment needed",
    "hepaticAdjustment": "Start with lower dose",
    "monitoringRequired": ["Blood pressure", "Heart rate", "Ankle swelling"],
    "specialInstructions": "Can be taken with or without food. Ankle swelling is common but not dangerous. Very commonly used in Iraq."
  },
  {
    "genericName": "Enalapril",
    "brandNames": ["Renitec", "Vasotec", "Envas"],
    "nameAr": "إنالابريل",
    "drugClass": "ACE Inhibitor",
    "mechanism": "Inhibits angiotensin-converting enzyme, reducing angiotensin II and aldosterone",
    "indications": ["Hypertension", "Heart failure", "Diabetic nephropathy", "Post-myocardial infarction"],
    "contraindications": ["Pregnancy", "Angioedema history", "Bilateral renal artery stenosis"],
    "sideEffects": ["Dry cough (10-20%)", "Hyperkalemia", "Dizziness", "Angioedema (rare)", "Acute kidney injury"],
    "interactions": ["NSAIDs (reduce effectiveness, increase kidney injury risk)", "Potassium supplements", "Spironolactone"],
    "dosageAdult": "Start 5mg once daily, usual 10-20mg/day, max 40mg/day",
    "dosagePediatric": "0.08mg/kg once daily, max 5mg/day",
    "dosageElderly": "Start 2.5mg once daily",
    "routeOfAdministration": "Oral",
    "availabilityIraq": "widely_available",
    "approximateCost": "5,000-15,000 IQD per month",
    "requiresPrescription": true,
    "pregnancyCategory": "D",
    "lactationSafety": "Use caution",
    "renalAdjustment": "Reduce dose if CrCl <30",
    "hepaticAdjustment": "No adjustment usually needed",
    "monitoringRequired": ["Blood pressure", "Kidney function and electrolytes within 1-2 weeks", "Potassium"],
    "specialInstructions": "Avoid in pregnancy. Check kidney function before starting. Dry cough is common - switch to ARB if intolerable. Widely available in Iraq."
  },
  {
    "genericName": "Hydrochlorothiazide",
    "brandNames": ["Esidrex", "Microzide", "HCT"],
    "nameAr": "هيدروكلوروثيازيد",
    "drugClass": "Thiazide Diuretic",
    "mechanism": "Inhibits sodium reabsorption in distal tubule, promoting diuresis",
    "indications": ["Hypertension", "Edema", "Heart failure"],
    "contraindications": ["Anuria", "Sulfa allergy", "Severe kidney disease"],
    "sideEffects": ["Hypokalemia", "Hyponatremia", "Hyperuricemia/gout", "Hyperglycemia", "Hyperlipidemia", "Photosensitivity"],
    "interactions": ["NSAIDs", "Lithium (increased toxicity)", "Digoxin (hypokalemia increases toxicity)"],
    "dosageAdult": "12.5-25mg once daily, max 50mg/day",
    "dosagePediatric": "1-2mg/kg/day",
    "dosageElderly": "Start 12.5mg daily",
    "routeOfAdministration": "Oral",
    "availabilityIraq": "widely_available",
    "approximateCost": "3,000-10,000 IQD per month",
    "requiresPrescription": true,
    "pregnancyCategory": "B",
    "lactationSafety": "Compatible",
    "renalAdjustment": "Ineffective if CrCl <30",
    "hepaticAdjustment": "Use caution",
    "monitoringRequired": ["Electrolytes (especially potassium)", "Kidney function", "Uric acid", "Glucose"],
    "specialInstructions": "Take in morning to avoid nocturia. Monitor potassium. Very affordable and commonly used in Iraq."
  },
  {
    "genericName": "Salbutamol (Albuterol)",
    "brandNames": ["Ventolin", "Proventil", "Airomir"],
    "nameAr": "سالبوتامول",
    "drugClass": "Short-Acting Beta-2 Agonist (SABA)",
    "mechanism": "Bronchodilation via beta-2 receptor stimulation",
    "indications": ["Asthma (acute relief)", "COPD", "Exercise-induced bronchospasm"],
    "contraindications": ["Hypersensitivity"],
    "sideEffects": ["Tremor", "Tachycardia", "Palpitations", "Headache", "Hypokalemia (high doses)"],
    "interactions": ["Beta-blockers (antagonize effect)", "MAO inhibitors"],
    "dosageAdult": "2 puffs (100mcg/puff) every 4-6 hours as needed, max 8 puffs/day",
    "dosagePediatric": "1-2 puffs every 4-6 hours as needed",
    "dosageElderly": "Same as adult",
    "routeOfAdministration": "Inhalation (MDI, nebulizer)",
    "availabilityIraq": "widely_available",
    "approximateCost": "10,000-25,000 IQD per inhaler",
    "requiresPrescription": true,
    "pregnancyCategory": "C",
    "lactationSafety": "Compatible",
    "renalAdjustment": "No adjustment needed",
    "hepaticAdjustment": "No adjustment needed",
    "monitoringRequired": ["Frequency of use (if using >2x/week, need controller)", "Heart rate", "Tremor"],
    "specialInstructions": "Teach proper inhaler technique. Use spacer if available. If needing >2x/week, add inhaled corticosteroid. Widely available in Iraq."
  },
  {
    "genericName": "Beclomethasone",
    "brandNames": ["Qvar", "Becotide", "Clenil"],
    "nameAr": "بيكلوميثازون",
    "drugClass": "Inhaled Corticosteroid (ICS)",
    "mechanism": "Anti-inflammatory, reduces airway inflammation",
    "indications": ["Asthma (controller)", "COPD"],
    "contraindications": ["Primary treatment of status asthmaticus", "Hypersensitivity"],
    "sideEffects": ["Oral thrush", "Hoarseness", "Cough", "Adrenal suppression (high doses)"],
    "interactions": ["Minimal systemic interactions"],
    "dosageAdult": "Low dose: 200-500mcg/day, Medium: 500-1000mcg/day, High: >1000mcg/day, divided twice daily",
    "dosagePediatric": "Low dose: 100-200mcg/day, Medium: 200-400mcg/day",
    "dosageElderly": "Same as adult",
    "routeOfAdministration": "Inhalation (MDI)",
    "availabilityIraq": "widely_available",
    "approximateCost": "15,000-35,000 IQD per inhaler",
    "requiresPrescription": true,
    "pregnancyCategory": "C",
    "lactationSafety": "Compatible",
    "renalAdjustment": "No adjustment needed",
    "hepaticAdjustment": "No adjustment needed",
    "monitoringRequired": ["Asthma control", "Growth in children", "Oral examination for thrush"],
    "specialInstructions": "Rinse mouth after use to prevent thrush. Use daily even when feeling well. Not for acute relief. Widely available in Iraq."
  },
  {
    "genericName": "Amoxicillin",
    "brandNames": ["Amoxil", "Trimox", "Moxacin"],
    "nameAr": "أموكسيسيلين",
    "drugClass": "Penicillin Antibiotic",
    "mechanism": "Inhibits bacterial cell wall synthesis",
    "indications": ["Respiratory tract infections", "UTI", "Otitis media", "Sinusitis", "H. pylori eradication"],
    "contraindications": ["Penicillin allergy", "Infectious mononucleosis"],
    "sideEffects": ["Diarrhea", "Nausea", "Rash", "Allergic reactions"],
    "interactions": ["Oral contraceptives (reduced effectiveness)", "Warfarin (increased INR)"],
    "dosageAdult": "250-500mg three times daily or 875mg twice daily for 5-10 days",
    "dosagePediatric": "20-40mg/kg/day divided three times daily",
    "dosageElderly": "Same as adult, adjust for kidney function",
    "routeOfAdministration": "Oral",
    "availabilityIraq": "widely_available",
    "approximateCost": "5,000-15,000 IQD per course",
    "requiresPrescription": true,
    "pregnancyCategory": "B",
    "lactationSafety": "Compatible",
    "renalAdjustment": "Reduce dose if CrCl <30",
    "hepaticAdjustment": "No adjustment needed",
    "monitoringRequired": ["Allergic reactions", "Diarrhea"],
    "specialInstructions": "Complete full course. Can be taken with or without food. Very commonly used and affordable in Iraq."
  },
  {
    "genericName": "Azithromycin",
    "brandNames": ["Zithromax", "Azithrocin", "Zmax"],
    "nameAr": "أزيثروميسين",
    "drugClass": "Macrolide Antibiotic",
    "mechanism": "Inhibits bacterial protein synthesis",
    "indications": ["Respiratory tract infections", "Atypical pneumonia", "Sinusitis", "Skin infections", "Chlamydia"],
    "contraindications": ["Macrolide allergy", "Severe liver disease"],
    "sideEffects": ["Diarrhea", "Nausea", "Abdominal pain", "QT prolongation (rare)"],
    "interactions": ["Warfarin", "Digoxin", "Antacids (reduce absorption)"],
    "dosageAdult": "500mg day 1, then 250mg days 2-5 (Z-pack)",
    "dosagePediatric": "10mg/kg day 1, then 5mg/kg days 2-5",
    "dosageElderly": "Same as adult",
    "routeOfAdministration": "Oral",
    "availabilityIraq": "widely_available",
    "approximateCost": "10,000-25,000 IQD per course",
    "requiresPrescription": true,
    "pregnancyCategory": "B",
    "lactationSafety": "Compatible",
    "renalAdjustment": "No adjustment needed",
    "hepaticAdjustment": "Use caution in severe disease",
    "monitoringRequired": ["Diarrhea", "Liver function if prolonged use"],
    "specialInstructions": "Take on empty stomach (1 hour before or 2 hours after meals). Short course convenient for compliance. Widely available in Iraq."
  },
  {
    "genericName": "Ciprofloxacin",
    "brandNames": ["Cipro", "Ciproxin", "Ciprobay"],
    "nameAr": "سيبروفلوكساسين",
    "drugClass": "Fluoroquinolone Antibiotic",
    "mechanism": "Inhibits bacterial DNA gyrase and topoisomerase",
    "indications": ["UTI", "Pyelonephritis", "Prostatitis", "Typhoid fever", "Traveler's diarrhea"],
    "contraindications": ["Children <18 years (except specific indications)", "Pregnancy", "Tendon disorders", "Myasthenia gravis"],
    "sideEffects": ["Nausea", "Diarrhea", "Tendon rupture (rare)", "QT prolongation", "Photosensitivity", "CNS effects"],
    "interactions": ["Antacids (reduce absorption)", "Warfarin (increased INR)", "Theophylline"],
    "dosageAdult": "250-750mg twice daily for 3-14 days depending on indication",
    "dosagePediatric": "Generally avoided, except for specific indications",
    "dosageElderly": "Adjust for kidney function",
    "routeOfAdministration": "Oral, IV",
    "availabilityIraq": "widely_available",
    "approximateCost": "10,000-30,000 IQD per course",
    "requiresPrescription": true,
    "pregnancyCategory": "C",
    "lactationSafety": "Use caution",
    "renalAdjustment": "Reduce dose if CrCl <50",
    "hepaticAdjustment": "No adjustment needed",
    "monitoringRequired": ["Tendon pain", "CNS effects", "Kidney function"],
    "specialInstructions": "Avoid in children and pregnancy. Take 2 hours before or 6 hours after antacids. Stop if tendon pain. Widely available but overused in Iraq - reserve for appropriate indications."
  },
  {
    "genericName": "Omeprazole",
    "brandNames": ["Losec", "Prilosec", "Omez"],
    "nameAr": "أوميبرازول",
    "drugClass": "Proton Pump Inhibitor (PPI)",
    "mechanism": "Irreversibly inhibits gastric H+/K+ ATPase (proton pump)",
    "indications": ["GERD", "Peptic ulcer", "H. pylori eradication", "Zollinger-Ellison syndrome"],
    "contraindications": ["Hypersensitivity"],
    "sideEffects": ["Headache", "Diarrhea", "Abdominal pain", "Vitamin B12 deficiency (long-term)", "Osteoporosis risk (long-term)", "C. difficile risk"],
    "interactions": ["Clopidogrel (reduced effectiveness)", "Warfarin", "Methotrexate"],
    "dosageAdult": "20-40mg once daily before breakfast",
    "dosagePediatric": "≥1 year: 10-20mg once daily",
    "dosageElderly": "Same as adult",
    "routeOfAdministration": "Oral",
    "availabilityIraq": "widely_available",
    "approximateCost": "5,000-20,000 IQD per month",
    "requiresPrescription": true,
    "pregnancyCategory": "C",
    "lactationSafety": "Probably compatible",
    "renalAdjustment": "No adjustment needed",
    "hepaticAdjustment": "Reduce dose in severe disease",
    "monitoringRequired": ["Symptom improvement", "Vitamin B12 if long-term", "Bone density if long-term"],
    "specialInstructions": "Take 30 minutes before breakfast. Swallow whole, do not crush. Use lowest effective dose for shortest duration. Very commonly used in Iraq."
  },
  {
    "genericName": "Paracetamol (Acetaminophen)",
    "brandNames": ["Panadol", "Tylenol", "Adol"],
    "nameAr": "باراسيتامول",
    "drugClass": "Analgesic, Antipyretic",
    "mechanism": "Inhibits prostaglandin synthesis in CNS, reduces fever",
    "indications": ["Pain (mild to moderate)", "Fever"],
    "contraindications": ["Severe liver disease", "Hypersensitivity"],
    "sideEffects": ["Hepatotoxicity (overdose)", "Rash (rare)"],
    "interactions": ["Warfarin (increased INR with chronic use)", "Alcohol (increased hepatotoxicity)"],
    "dosageAdult": "500-1000mg every 4-6 hours, max 4000mg/day",
    "dosagePediatric": "10-15mg/kg every 4-6 hours, max 75mg/kg/day",
    "dosageElderly": "Same as adult, but consider lower doses",
    "routeOfAdministration": "Oral, IV, rectal",
    "availabilityIraq": "widely_available",
    "approximateCost": "2,000-5,000 IQD per pack",
    "requiresPrescription": false,
    "pregnancyCategory": "B",
    "lactationSafety": "Compatible",
    "renalAdjustment": "Increase dosing interval if CrCl <30",
    "hepaticAdjustment": "Avoid in severe liver disease",
    "monitoringRequired": ["Liver function if chronic use", "Daily dose (avoid overdose)"],
    "specialInstructions": "Very safe if used correctly. Do not exceed 4g/day. Avoid alcohol. Most commonly used pain/fever medication in Iraq. Very affordable."
  },
  {
    "genericName": "Ibuprofen",
    "brandNames": ["Brufen", "Advil", "Motrin"],
    "nameAr": "إيبوبروفين",
    "drugClass": "NSAID",
    "mechanism": "Inhibits COX-1 and COX-2, reducing prostaglandin synthesis",
    "indications": ["Pain (mild to moderate)", "Fever", "Inflammation", "Dysmenorrhea"],
    "contraindications": ["Peptic ulcer", "Severe heart failure", "Severe kidney disease", "Aspirin allergy", "Third trimester pregnancy"],
    "sideEffects": ["GI upset", "Peptic ulcer", "GI bleeding", "Kidney injury", "Cardiovascular events (high doses)"],
    "interactions": ["Warfarin (increased bleeding)", "ACE inhibitors (reduced effectiveness, increased kidney injury)", "Aspirin (reduced antiplatelet effect)"],
    "dosageAdult": "200-400mg every 4-6 hours, max 2400mg/day",
    "dosagePediatric": "≥6 months: 5-10mg/kg every 6-8 hours, max 40mg/kg/day",
    "dosageElderly": "Use lowest effective dose",
    "routeOfAdministration": "Oral",
    "availabilityIraq": "widely_available",
    "approximateCost": "3,000-10,000 IQD per pack",
    "requiresPrescription": false,
    "pregnancyCategory": "C (D in third trimester)",
    "lactationSafety": "Compatible",
    "renalAdjustment": "Avoid if CrCl <30",
    "hepaticAdjustment": "Use caution",
    "monitoringRequired": ["GI symptoms", "Kidney function", "Blood pressure"],
    "specialInstructions": "Take with food to reduce GI upset. Use lowest effective dose for shortest duration. Avoid in elderly with kidney disease or heart failure. Very commonly used in Iraq."
  },
  {
    "genericName": "Diclofenac",
    "brandNames": ["Voltaren", "Cataflam", "Dicloflex"],
    "nameAr": "ديكلوفيناك",
    "drugClass": "NSAID",
    "mechanism": "Inhibits COX-1 and COX-2, reducing prostaglandin synthesis",
    "indications": ["Pain", "Inflammation", "Osteoarthritis", "Rheumatoid arthritis", "Ankylosing spondylitis"],
    "contraindications": ["Peptic ulcer", "Severe heart failure", "Severe kidney disease", "Aspirin allergy", "Third trimester pregnancy", "History of cardiovascular disease"],
    "sideEffects": ["GI upset", "Peptic ulcer", "GI bleeding", "Kidney injury", "Cardiovascular events", "Hepatotoxicity"],
    "interactions": ["Warfarin", "ACE inhibitors", "Aspirin", "Methotrexate"],
    "dosageAdult": "50mg 2-3 times daily or 75mg twice daily (SR formulation)",
    "dosagePediatric": "Not recommended",
    "dosageElderly": "Use lowest effective dose",
    "routeOfAdministration": "Oral, topical, IM",
    "availabilityIraq": "widely_available",
    "approximateCost": "5,000-15,000 IQD per pack",
    "requiresPrescription": true,
    "pregnancyCategory": "C (D in third trimester)",
    "lactationSafety": "Use caution",
    "renalAdjustment": "Avoid if CrCl <30",
    "hepaticAdjustment": "Use caution, monitor liver function",
    "monitoringRequired": ["GI symptoms", "Kidney function", "Liver function", "Cardiovascular risk"],
    "specialInstructions": "Higher cardiovascular risk than other NSAIDs. Avoid in patients with heart disease. Take with food. Very commonly used in Iraq but should be used cautiously."
  }
]
